![Katherine Rielly-Gauvin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katherine Rielly-Gauvin
Directeur/Membre du Conseil chez
LIQUIDIA CORPORATION
Fortune : 3 M $ au 31/05/2026
Profil
Katherine Rielly-Gauvin is currently an Independent Director at Liquidia Technologies, Inc. since 2019 and at Liquidia Corp.
since 2020.
Formerly, Ms. Rielly-Gauvin was Vice President-Global Commercial Development at AbbVie, Inc. from 2013 to 2023 and VP & General Manager-Commercial CNS at Janssen Pharmaceuticals, Inc. Education includes an undergraduate degree from Simmons University and an MBA from Rutgers University-Newark.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,05 % | 16/06/2026 | 44 637 ( 0,05 % ) | 3 M $ | 31/05/2026 |
Postes actifs de Katherine Rielly-Gauvin
| Sociétés | Poste | Début |
|---|---|---|
| LIQUIDIA CORPORATION | Directeur/Membre du Conseil | 28/06/2020 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Directeur/Membre du Conseil | 30/10/2019 |
Anciens postes connus de Katherine Rielly-Gauvin
| Sociétés | Poste | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/07/2023 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | - |
Formation de Katherine Rielly-Gauvin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Simmons University
 Simmons University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers University- Newark
 Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Choisissez Zonebourse 
